Excerpt from Hemophilia, Musculoskeletal Complications


Synonyms, Key Words, and Related Terms: hemophilic arthropathy, hemophilic soft-tissue bleeding, pseudotumor, hemophilia A, classic hemophilia, factor VIII deficiency, hemophilia B, Christmas disease, factor IX deficiency, bleeding disorder

Please click here to view the full topic text: Hemophilia, Musculoskeletal Complications

Background: Hemophilia is the oldest known bleeding disorder. It first came to public attention when the disease appeared in the offspring of Queen Victoria of England (Aronova-Tiuntseva, 2002). Presumably, this disease occurred because of a mutation in one of Queen Elizabeth's X chromosomes. Close intermarriages between European royalty caused the disease to spread from the English royal families to the German, Spanish, and Russian royal families in the 19th and 20th centuries. The mechanism for the bleeding was not known. However, in 1868, the physician Volkmann defined the role of hemorrhage in the pathogenesis of the articular findings in hemophilia (Resnick, 2002).

Pathophysiology: The deficiency or absence of either of 2 clotting elements—factor VIII or factor IX—leads to the clinical conditions described as hemophilia A or hemophilia B, respectively. Hemophilia B was formerly known as Christmas disease. In this disease, life-threatening bleeding into the head or the abdomen may occur at any age and is not described in this article.

People with one of these bleeding disorders are prone to have recurrent episodes of hemorrhage into the joints. Acute bleeding increases the pressure in the synovial cavity and bone marrow, which leads to severe pain and possibly osteonecrosis or a pseudotumoral mass. Intra-articular bleeding produces a direct chemical effect on the synovium, cartilage, and bone. Over time, the blood becomes deposited in the form of hemosiderin in these tissues.

Recurrent hyperemia of the joint in the growing child causes juxta-articular osteoporosis and overgrowth of the epiphysis.

Roosendaal and Lafeber studied the pathogenesis of the joint changes in both experimental and clinical cases (Roosendaal, 2003). They found that the articular cartilage is sensitive to the presence of blood and that damage may occur to the cartilage independent of the synovial changes caused by bleeding. However, practically speaking, the imaging changes that appear first are effusion and synovial proliferation. Damage to the bone and articular cartilage appears later.

Frequency:

  • In the US: An estimated 20,000 persons in the United States have hemophilia A, which accounts for 75% of all cases of hemophilia (see Hemophilia, Overview). Women are rarely affected. Homozygous disease has been reported in females, as well as in Turner (XO) syndrome (see Images 1-2).
  • Internationally: Hemophilia affects all races and has been reported from all parts of the world. The World Federation of Hemophilia and philanthropic groups have attempted to aid families living in developing countries who have this condition. Current descendents of the royal families in England and Spain appear to be free of either the disease or the female-carrier state.

Mortality/Morbidity: The severity of the disease varies.

  • Beginning in the early 1980s and continuing to the present, AIDS has been a significant complication of hemophilia. The use of plasma-derived factor replacement from pooled plasma sources led to 50% of hemophiliacs developing AIDS in the 1980s (see Hemophilia, Overview). Since the time when the risk of transfusion-related HIV transmission was recognized, the prevalence of new cases of AIDS in hemophiliac cases has decreased to nearly zero.

    Screening for HIV products in blood is effective, but there is still concern that other agents, such as hepatitis A, parvovirus, and that causing Creutzfeldt-Jakob disease, can still be transmitted in blood transfusions. In developed countries, recombinant factor VIII is produced synthetically without blood products; this development has allayed fears .....

    Please click here to view the full topic text: Hemophilia, Musculoskeletal Complications